Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
NCT00167908 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2009-02-04
Summary
The purpose of this study is to determine whether Amifostine provides additional protection of salivary gland function over that achieved with IMRT alone.
Conditions
Interventions
- DRUG
-
Ethyol (drug)
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Wade Thorstad, M.D. · Washington University School of Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
- Completion
- 2007-05-31
More Related Trials
-
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
NCT00318890 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
NCT00003251 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
NCT00137358 ·Status: WITHDRAWN ·Phase: PHASE1
-
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
NCT04440917 ·Status: UNKNOWN ·Phase: PHASE2
-
Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
NCT00012012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
NCT00274937 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
NCT00025298 ·Status: TERMINATED ·Phase: PHASE2
-
Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial
NCT04413214 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer
NCT00858663 ·Status: COMPLETED ·Phase: PHASE1
-
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
NCT00003777 ·Status: TERMINATED ·Phase: PHASE2
-
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
NCT04169074 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer
NCT00131638 ·Status: COMPLETED ·Phase: PHASE3
-
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
NCT05351762 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
NCT01283178 ·Status: TERMINATED ·Phase: PHASE1
-
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00415025 ·Status: COMPLETED
-
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT00957086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
NCT00014118 ·Status: COMPLETED ·Phase: PHASE2
-
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
NCT06364826 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
NCT06490341 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
NCT04529850 ·Status: COMPLETED ·Phase: PHASE2
-
SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00095628 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of APG-157 in Head and Neck Cancer
NCT05312710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
NCT05010629 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
NCT00485485 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN
NCT04949503 ·Status: COMPLETED